Beryl Capital Management’s Epizyme, Inc EPZM Stock Holding History

Beryl Capital Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,394,821	Closed	-$2.05M	–	56
2022 Q2	$2.05M	Buy	+1,394,821	New	+$1.03M	0.21%	39

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Beryl Capital Management's EPZM Position: Q3 2022 in Review

Beryl Capital Management sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 1,394,821 shares — an estimated $2.05M sold.

Beryl Capital Management first reported a position in EPZM in Q2 2022 and held it in 1 quarter. The position peaked at $2.05M in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Beryl Capital Management reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Beryl Capital Management sold 1,394,821 Epizyme, Inc shares in Q3 2022, an estimated $2.05M.
Beryl Capital Management first reported a position in Epizyme, Inc in Q2 2022 and held it in 1 quarter.
Beryl Capital Management's Epizyme, Inc position peaked at $2.05M in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Beryl Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.